Neutralization of the SARS-CoV-2 omicron BA. 4/5 and BA. 2.12. 1 subvariants P Qu, J Faraone, JP Evans, X Zou, YM Zheng, C Carlin, JS Bednash, ... New England Journal of Medicine 386 (26), 2526-2528, 2022 | 172 | 2022 |
Neutralization of SARS-CoV-2 Omicron sub-lineages BA. 1, BA. 1.1, and BA. 2 JP Evans, C Zeng, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... Cell host & microbe 30 (8), 1093-1102. e3, 2022 | 116 | 2022 |
Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor‐associated fibroblasts in preclinical models SE Wheeler, H Shi, F Lin, S Dasari, J Bednash, S Thorne, S Watkins, ... Head & neck 36 (3), 385-392, 2014 | 111 | 2014 |
Neutralization and stability of SARS-CoV-2 Omicron variant C Zeng, JP Evans, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... biorxiv, 2021 | 88 | 2021 |
Regulation of inflammasomes by ubiquitination JS Bednash, RK Mallampalli Cellular & molecular immunology 13 (6), 722-728, 2016 | 85 | 2016 |
Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma RJ Leeman-Neill, RR Seethala, SV Singh, ML Freilino, JS Bednash, ... Cancer prevention research 4 (2), 230-237, 2011 | 71 | 2011 |
Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity JS Bednash, N Weathington, J Londino, M Rojas, DL Gulick, R Fort, ... Nature communications 8 (1), 15203, 2017 | 53 | 2017 |
Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation EA Lendermon, TA Coon, JS Bednash, NM Weathington, JF McDyer, ... Respiratory Research 18, 1-8, 2017 | 47 | 2017 |
Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling JS Bednash, VE Kagan, JA Englert, D Farkas, YY Tyurina, VA Tyurin, ... Translational Research 240, 1-16, 2022 | 44 | 2022 |
The deubiquitinase STAMBP modulates cytokine secretion through the NLRP3 inflammasome JS Bednash, F Johns, N Patel, TR Smail, JD Londino, RK Mallampalli Cellular signalling 79, 109859, 2021 | 38 | 2021 |
Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer SE Wheeler, EM Morariu, JS Bednash, CG Otte, RR Seethala, SI Chiosea, ... Clinical Cancer Research 18 (10), 2850-2860, 2012 | 38 | 2012 |
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 Omicron BA. 2.86 and FLip variants P Qu, K Xu, JN Faraone, N Goodarzi, YM Zheng, C Carlin, JS Bednash, ... Biorxiv, 2023 | 29 | 2023 |
Neutralization of the SARS-CoV-2 deltacron and BA. 3 variants JP Evans, P Qu, C Zeng, YM Zheng, C Carlin, JS Bednash, G Lozanski, ... New England Journal of Medicine 386 (24), 2340-2342, 2022 | 26 | 2022 |
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA. 2.86 and FLip variants P Qu, K Xu, JN Faraone, N Goodarzi, YM Zheng, C Carlin, JS Bednash, ... Cell 187 (3), 585-595. e6, 2024 | 24 | 2024 |
RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity AC McKelvey, TB Lear, SR Dunn, J Evankovich, JD Londino, JS Bednash, ... Elife 5, e18496, 2016 | 21 | 2016 |
Differential evasion of Delta and Omicron immunity and enhanced fusogenicity of SARS-CoV-2 Omicron BA. 4/5 and BA. 2.12. 1 subvariants P Qu, JN Faraone, JP Evans, X Zou, YM Zheng, C Carlin, JS Bednash, ... BioRxiv, 2022.05. 16.492158, 2022 | 17 | 2022 |
Interferon lambda signaling in macrophages is necessary for the antiviral response to influenza RK Mallampalli, J Adair, A Elhance, D Farkas, L Chafin, ME Long, M De, ... Frontiers in immunology 12, 735576, 2021 | 17 | 2021 |
Neutralization and stability of SARS-CoV-2 Omicron variant. bioRxiv 2021 C Zeng, JP Evans, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ... Preprint]. doi 2016, 2021 | 14 | 2021 |
Targeting deubiquitinases in cancer JS Bednash, RK Mallampalli Proteases and Cancer: Methods and Protocols, 295-305, 2018 | 12 | 2018 |
The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis D Chandra, J Londino, S Alexander, JS Bednash, Y Zhang, ... Journal of molecular and cellular cardiology 126, 50-59, 2019 | 11 | 2019 |